Revenue Summary of PharmChem, Inc.

PharmChem, Inc.'s latest annual revenue in 2023 was 6.01 Million USD , up 3.0% from previous year.
PharmChem, Inc.'s latest quarterly revenue in 2024 Q1 was 1.44 Million USD , up 3.09% from previous quarter.
PharmChem, Inc. reported a annual revenue of 5.83 Million USD in annual revenue 2022, down -6.15% from previous year.
PharmChem, Inc. reported a annual revenue of 6.22 Million USD in annual revenue 2021, down -6.71% from previous year.
PharmChem, Inc. reported a quarterly revenue of 1.54 Million USD for 2024 Q2, up 6.59% from previous quarter.
PharmChem, Inc. reported a quarterly revenue of 1.5 Million USD for 2023 Q1, up 10.31% from previous quarter.

Annual Revenue Chart of PharmChem, Inc. (2023 - 1989)

Historical Annual Revenue of PharmChem, Inc. (2023 - 1989)

Year	Revenue	Revenue Growth
2023	6.01 Million USD	3.0%
2022	5.83 Million USD	-6.15%
2021	6.22 Million USD	-6.71%
2020	6.66 Million USD	20.34%
2019	5.54 Million USD	7.36%
2018	5.16 Million USD	10.02%
2017	4.69 Million USD	12.53%
2016	4.16 Million USD	0.0%
2002	30.08 Million USD	-31.59%
2001	43.97 Million USD	-6.1%
2000	46.83 Million USD	5.27%
1999	44.48 Million USD	3.05%
1998	43.17 Million USD	10.04%
1997	39.23 Million USD	-4.9%
1996	41.25 Million USD	5.51%
1995	39.1 Million USD	16.37%
1994	33.6 Million USD	15.86%
1993	29 Million USD	5.84%
1992	27.4 Million USD	13.69%
1991	24.1 Million USD	55.48%
1990	15.5 Million USD	50.49%
1989	10.3 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.44 Million USD	3.09%
2024 Q2	1.54 Million USD	6.59%
2023 Q1	1.5 Million USD	10.31%
2023 FY	6.01 Million USD	3.0%
2023 Q4	1.4 Million USD	-10.3%
2023 Q2	1.54 Million USD	2.56%
2023 Q3	1.56 Million USD	1.42%
2022 Q3	1.42 Million USD	-5.45%
2022 Q1	1.54 Million USD	7.46%
2022 Q2	1.5 Million USD	-2.09%
2022 FY	5.83 Million USD	-6.15%
2022 Q4	1.36 Million USD	-4.42%
2021 FY	6.22 Million USD	-6.71%
2021 Q3	1.61 Million USD	5.32%
2021 Q2	1.53 Million USD	-6.67%
2021 Q4	1.43 Million USD	-11.16%
2021 Q1	1.64 Million USD	0.0%
2020 FY	6.66 Million USD	20.34%
2019 FY	5.54 Million USD	7.36%
2018 FY	5.16 Million USD	10.02%
2017 FY	4.69 Million USD	12.53%
2016 FY	4.16 Million USD	0.0%
2003 Q1	6.33 Million USD	-12.34%
2003 Q3	6.94 Million USD	-2.42%
2003 Q2	7.11 Million USD	12.3%
2002 Q3	7.31 Million USD	-9.3%
2002 Q2	8.06 Million USD	7.89%
2002 Q4	7.22 Million USD	-1.22%
2002 FY	30.08 Million USD	-31.59%
2002 Q1	7.47 Million USD	-25.46%
2001 FY	43.97 Million USD	-6.1%
2001 Q3	11.61 Million USD	7.61%
2001 Q2	10.78 Million USD	-6.58%
2001 Q1	11.54 Million USD	-8.98%
2001 Q4	10.02 Million USD	-13.62%
2000 Q4	12.68 Million USD	6.12%
2000 Q3	11.95 Million USD	3.25%
2000 FY	46.83 Million USD	5.27%
2000 Q2	11.58 Million USD	9.16%
2000 Q1	10.6 Million USD	-6.02%
1999 Q3	11.9 Million USD	7.21%
1999 FY	44.48 Million USD	3.05%
1999 Q2	11.1 Million USD	8.82%
1999 Q1	10.2 Million USD	-6.18%
1999 Q4	11.28 Million USD	-5.15%
1998 FY	43.17 Million USD	10.04%
1998 Q1	9.5 Million USD	-6.25%
1998 Q2	11.5 Million USD	21.05%
1998 Q3	11.3 Million USD	-1.74%
1998 Q4	10.87 Million USD	-3.79%
1997 Q4	10.13 Million USD	1.33%
1997 Q1	9.1 Million USD	-8.59%
1997 FY	39.23 Million USD	-4.9%
1997 Q2	10 Million USD	9.89%
1997 Q3	10 Million USD	0.0%
1996 Q3	10.6 Million USD	-1.85%
1996 Q4	9.95 Million USD	-6.08%
1996 Q1	9.9 Million USD	-3.88%
1996 FY	41.25 Million USD	5.51%
1996 Q2	10.8 Million USD	9.09%
1995 Q4	10.3 Million USD	0.0%
1995 Q1	8.8 Million USD	-1.12%
1995 Q2	9.7 Million USD	10.23%
1995 Q3	10.3 Million USD	6.19%
1995 FY	39.1 Million USD	16.37%
1994 Q3	8.9 Million USD	5.95%
1994 Q4	8.9 Million USD	0.0%
1994 Q2	8.4 Million USD	12.0%
1994 Q1	7.5 Million USD	2.74%
1994 FY	33.6 Million USD	15.86%
1993 Q1	7.4 Million USD	4.23%
1993 Q2	7.3 Million USD	-1.35%
1993 Q3	7.1 Million USD	-2.74%
1993 Q4	7.3 Million USD	2.82%
1993 FY	29 Million USD	5.84%
1992 Q3	6.8 Million USD	-5.56%
1992 Q1	6.3 Million USD	-5.97%
1992 Q2	7.2 Million USD	14.29%
1992 FY	27.4 Million USD	13.69%
1992 Q4	7.1 Million USD	4.41%
1991 FY	24.1 Million USD	55.48%
1991 Q1	4.3 Million USD	10.26%
1991 Q2	6.6 Million USD	53.49%
1991 Q3	6.5 Million USD	-1.52%
1991 Q4	6.7 Million USD	3.08%
1990 Q3	3.9 Million USD	0.0%
1990 Q4	3.9 Million USD	0.0%
1990 Q2	3.9 Million USD	2.63%
1990 Q1	3.8 Million USD	46.15%
1990 FY	15.5 Million USD	50.49%
1989 Q1	2.5 Million USD	0.0%
1989 Q3	2.6 Million USD	0.0%
1989 Q4	2.6 Million USD	0.0%
1989 FY	10.3 Million USD	0.0%
1989 Q2	2.6 Million USD	4.0%

Peer Revenue Comparison of PharmChem, Inc.

Name	Revenue	Revenue Difference
American Bio Medica Corporation	913 Thousand USD	-558.533%
Arrayit Corporation	4.37 Million USD	-37.354%
Atlantic International Corp.	- USD	-Infinity%
Biocept, Inc.	25.85 Million USD	76.748%
Bioqual, Inc.	58.59 Million USD	89.738%
CardioGenics Holdings Inc	- USD	-Infinity%
DermTech, Inc.	15.29 Million USD	60.693%
Global WholeHealth Partners Corporation	- USD	-Infinity%
Hangzhou Tigermed Consulting Co., Ltd.	7.38 Billion USD	99.919%
HTG Molecular Diagnostics, Inc.	6.36 Million USD	5.558%
iMD Companies, Inc.	- USD	-Infinity%
IDenta Corp.	1.05 Million USD	-471.744%
Interpace Biosciences, Inc.	40.21 Million USD	85.049%
Integrative Health Technologies, Inc.	447.49 Thousand USD	-1243.557%
InVitro International	792.62 Thousand USD	-658.54%
Lumos Diagnostics Holdings Limited	11.13 Million USD	45.985%
Many Bright Ideas Technologies Inc.	- USD	-Infinity%
Medical Imaging Corp.	7.22 Million USD	16.774%
NovelStem International Corp.	12 Thousand USD	-50003.358%
Optigenex Inc.	465.97 Thousand USD	-1190.298%
Proteome Sciences plc	6.4 Million USD	6.066%
Response Genetics, Inc	18.04 Million USD	66.672%
Rennova Health, Inc.	13.03 Million USD	53.879%
RushNet, Inc.	1.78 Million USD	-236.287%
ScreenPro Security Inc.	1.91 Million USD	-214.111%
Stella Diagnostics Inc.	- USD	-Infinity%
StageZero Life Sciences Ltd.	3.79 Million USD	-58.426%
Todos Medical Ltd.	7.69 Million USD	21.866%

Global Stocks Search

PharmChem, Inc. (PCHM)

Revenue Summary of PharmChem, Inc.

Annual Revenue Chart of PharmChem, Inc. (2023 - 1989)

Historical Annual Revenue of PharmChem, Inc. (2023 - 1989)

Peer Revenue Comparison of PharmChem, Inc.